Zuclopenthixol Ong-Acting Im Injection (Depot) Suppliers & Bulk Manufacturers

Available Forms: Long-acting IM Injection (Depot)

Available Strengths: 200 mg/mL, 500 mg/mL

Reference Brands: Clopixol Depot®(US)

Category: Antipsychotropic Drugs

Zuclopenthixol ong-acting IM Injection (Depot) is available in Long-acting IM Injection (Depot) and strengths such as 200 mg/mL, 500 mg/mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Zuclopenthixol ong-acting IM Injection (Depot) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Zuclopenthixol ong-acting IM Injection (Depot) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Zuclopenthixol long-acting IM injection, a typical antipsychotic depot formulation, is not FDA-approved in the United States but is widely authorized in the EU under the brand Clopixol Depot. In Europe, it follows EMA guidelines for long-acting injectable neuroleptics, indicated for schizophrenia and related psychoses. EU compliance requires GMP manufacturing, stability data, and pharmacovigilance alignment. U.S. market entry may involve a 505(b)(2) pathway and complete ANDA dossier. To explore dossier-ready forms, formulations, and global suppliers of Zuclopenthixol long-acting IM injection, visit Pharmatradz.com.